These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 8232098

  • 21. Proteinuria, albumin synthesis and hyperlipidaemia in the nephrotic syndrome.
    Kaysen GA, Don B, Schambelan M.
    Nephrol Dial Transplant; 1991; 6(2):141-9. PubMed ID: 1857529
    [No Abstract] [Full Text] [Related]

  • 22. Lipoprotein profiles in adult nephrotics.
    Newmark SR, Anderson CF, Donadio JV, Ellefson RD.
    Mayo Clin Proc; 1975 Jul; 50(7):359-64. PubMed ID: 1152529
    [Abstract] [Full Text] [Related]

  • 23. High levels of tissue factor pathway inhibitor in patients with nephrotic proteinuria.
    Ariëns RA, Moia M, Rivolta E, Ponticelli C, Mannucci PM.
    Thromb Haemost; 1999 Sep; 82(3):1020-3. PubMed ID: 10494757
    [Abstract] [Full Text] [Related]

  • 24. Glomerular atherosclerosis.
    Moorhead JF, Brunton C, Varghese Z.
    Miner Electrolyte Metab; 1997 Sep; 23(3-6):287-90. PubMed ID: 9387135
    [Abstract] [Full Text] [Related]

  • 25. [Dyslipidemias in renal diseases: pathogenesis and treatment].
    Cuevas A, Maíz A, Arteaga A.
    Rev Med Chil; 1998 Mar; 126(3):315-21. PubMed ID: 9674303
    [Abstract] [Full Text] [Related]

  • 26. Pharmacological and dietary treatment of lipid abnormalities in nephrotic patients.
    D'Amico G, Gentile MG.
    Kidney Int Suppl; 1991 Apr; 31():S65-9. PubMed ID: 2046273
    [No Abstract] [Full Text] [Related]

  • 27. Astragalus mongholicus and Angelica sinensis compound alleviates nephrotic hyperlipidemia in rats.
    Li J, Yu L, Li N, Wang H.
    Chin Med J (Engl); 2000 Apr; 113(4):310-4. PubMed ID: 11775225
    [Abstract] [Full Text] [Related]

  • 28. The mechanism of hyperlipidaemia in the nephrotic syndrome.
    Dixit VM, Hettiaratchi ES.
    Med Hypotheses; 1979 Dec; 5(12):1327-31. PubMed ID: 231735
    [Abstract] [Full Text] [Related]

  • 29. Accumulation of atherogenic remnants and lipoprotein(a) in the nephrotic syndrome: relation to remission of proteinuria.
    Joven J, Simó JM, Vilella E, Camps J, Espinel E, Villabona C.
    Clin Chem; 1995 Jun; 41(6 Pt 1):908-13. PubMed ID: 7768011
    [Abstract] [Full Text] [Related]

  • 30. Statins and diabetes.
    Carmena R, Betteridge DJ.
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [Abstract] [Full Text] [Related]

  • 31. The effect of a thromboxane A2 synthase inhibitor on the dyslipoproteinemia of an inbred rat strain with spontaneous age-related nephrotic syndrome.
    Tarugi P, Nicolini S, Albertazzi L, Marchi L, Calandra S, Salvati P.
    Aging (Milano); 1994 Oct; 6(5):381-90. PubMed ID: 7893785
    [Abstract] [Full Text] [Related]

  • 32. Antilipaemic drugs and nephrotic hyperlipidaemia.
    Edwards KD.
    Prog Biochem Pharmacol; 1972 Oct; 7():370-426. PubMed ID: 4567423
    [No Abstract] [Full Text] [Related]

  • 33. Reduction in proteinuria attenuates hyperlipidemia in the nephrotic syndrome.
    Kaysen GA, Davies RW.
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S75-9. PubMed ID: 16989070
    [Abstract] [Full Text] [Related]

  • 34. [Physiopathology of protein and lipid metabolism in the nephrotic syndrome. Recent experimental and clinical data].
    Costică II, Dumitriu M.
    Fiziol Norm Patol; 1972 Nov; 18(2):145-54. PubMed ID: 5032189
    [No Abstract] [Full Text] [Related]

  • 35. [Hyperlipemia in nephrotic syndrome].
    Walasek L.
    Pol Tyg Lek; 1972 Jan 31; 27(5):189-91. PubMed ID: 4551652
    [No Abstract] [Full Text] [Related]

  • 36. Lipid lowering therapy in atherosclerosis.
    Aikawa M, Libby P.
    Semin Vasc Med; 2004 Nov 31; 4(4):357-66. PubMed ID: 15861316
    [Abstract] [Full Text] [Related]

  • 37. Cellular cholesterol efflux to plasma from proteinuric patients is elevated and remains unaffected by antiproteinuric treatment.
    Vogt L, Laverman GD, van Tol A, Groen AK, Navis G, Dullaart RP.
    Nephrol Dial Transplant; 2006 Jan 31; 21(1):101-6. PubMed ID: 16141462
    [Abstract] [Full Text] [Related]

  • 38. High lipid levels in very low density lipoprotein and intermediate density lipoprotein may cause proteinuria and glomerulosclerosis in aging female analbuminemic rats.
    Joles JA, van Goor H, van der Horst ML, van Tol A, Elema JD, Koomans HA.
    Lab Invest; 1995 Dec 31; 73(6):912-21. PubMed ID: 8558854
    [Abstract] [Full Text] [Related]

  • 39. Statins in nephrotic syndrome: a new weapon against tissue injury.
    Buemi M, Nostro L, Crascì E, Barillà A, Cosentini V, Aloisi C, Sofi T, Campo S, Frisina N.
    Med Res Rev; 2005 Nov 31; 25(6):587-609. PubMed ID: 16075407
    [Abstract] [Full Text] [Related]

  • 40. [Relations between the degree of kidney damage and disorders of serum lipoprotein concentration in children with nephrotic syndrome].
    Jovanović S.
    Med Pregl; 1977 Nov 31; 30(3-4):153-8. PubMed ID: 875922
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.